Filtered By:
Vaccination: Malaria Vaccine
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 36 results found since Jan 2013.
The Most Important Book Written This Decade
In Western Pennsylvania there is a small town by the name of Roseto.
Settled in 1912 by immigrant Italian families coming to the New World it was like a 1,000 other similar towns all over the USA.
Except that is, for one striking detail.
It was noticed in the early 1960’s that the inhabitants of Roseto had strikingly low levels of heart disease and far lower occurrences of heart attacks than surrounding communities.
We all know that not smoking, exercising regularly, drinking in moderation and eating well are amongst the keystones habits to good health, which is what made the findings so puzzling to the scientists pourin...
Source: Life Coach Blog: The Discomfort Zone : - August 18, 2013 Category: Life Coaches Authors: Tim Brownson Tags: Reviews & Previews Source Type: blogs
What is BUKO Pharma-Kampagne?
http://www.en.bukopharma.de/BUKO Pharma-Kampagne was founded with the aim of examining the activities of the German pharmaceutical industry in Third World countries. We want to implement changes by taking special actions and informing the public in detail. Pharma-Kampagne is a campaigning group of the Bundeskoordination Internationalismus(BUKO) (Federal Coordination of Internationalism) uniting 130 German action and solidarity groups working in favour of the Third World. More than 20 years ago, BUKO Pharma-Kampagne started to pay attention to the theme "Drugs and the Third World ". Today it is one of the fe...
Source: PharmaGossip - May 28, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs
How Drug Companies Keep Medicine Out of Reach - The Atlantic
http://www.theatlantic.com/health/archive/2013/05/how-drug-companies-keep-medicine-out-of-reach/275853/?ReutersFor almost a decade, the United States has been standing in the way of an idea that could lead to cures for some of the world's most devastating illnesses. The class of maladies is known as neglected diseases, and they almost exclusively affect those in the developing world. The same idea, if realized, might also be used in more affluent nations to goad the pharmaceutical industry into producing critical innovations that the free market has yet to produce - things like new antibiotics, which are likely to be used ...
Source: PharmaGossip - May 15, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs
Drug donations are great, but should Big Pharma be setting the agenda?
Monday 29 April 2013 12.01 BST
Critics fear that giving out free medicines allows pharmaceutical companies to decide which diseases are treated
Vaccine donations might end after a period of time, leaving governments to pick up the bill. Photograph: Chris Hondros/Getty Images
Adam Robert Green for African Arguments, part of the Guardian Africa Network
In the early 2000s, pharmaceutical companies were high on activists' hit lists, prompted by Big Pharma's ill-advised attempt to sue the South African government for patent infringement on HIV drugs; an attempt to deal with the country's epidemic by allowing cheaper, generi...
Source: PharmaGossip - April 30, 2013 Category: Pharma Commentators Authors: insider Source Type: blogs
PhRMA Report: Over 5400 Medicines in Development and 70% are First in Class
According to report released by PhRMA, companies have more than 5,400 medicines in development globally, and more than 70% of therapies in the pipeline are potentially first-in-class and could offer patients new treatment options, and a notable number of potential therapies target diseases with limited treatment options such as ALS and rare diseases. A breakdown of their report offers insight into the various medicines in development for different diseases and populations.
Older Americans
America’s biopharmaceutical research companies are developing 465 new medicines that target the 10 leading chronic conditi...
Source: Policy and Medicine - April 24, 2013 Category: Health Medicine and Bioethics Commentators Authors: Thomas Sullivan Source Type: blogs
Indian Court Wants Stricter Clinical Trial Oversight
Amid ongoing concern over the conduct of clinical trials in India and patient protection, the Indian Supreme Court has slammed regulators for shoddy oversight that is creating “havoc” and leading to the deaths of many citizens.
In sharp remarks, the government was criticized for going into a “deep slumber” and failing to establish mechanisms to stop “rackets” of multinational drugmakers, which are allegedly conducting illegal clinical trials around the country, according to various media reports (see here and here).
“There has to be some sense of responsibility (on the part of the government). Hu...
Source: Pharmalot - January 7, 2013 Category: Pharma Commentators Authors: Ed Silverman Tags: Uncategorized Clinical Trials GlaxoSmithKline HPV India Vaccines Source Type: blogs
